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Uncontrolled leakage of urine at an inappropriate 
time and place after 5 years of age is known as 
incontinence. 
 
Primary Nocturnal enuresis (NE) is enuresis in a child 
who has previously been dry for less than 6 months. 
Secondary enuresis is enuresis in a child who has 
previously been dry for at least 6 months. 
Monosymptomatic enuresis is enuresis in a child 
without any (other) lower urinary tract symptoms. 
Non-monosymptomatic enuresis is enuresis in a child 
with (other) lower urinary tract symptoms, such as 
daytime urgency, frequency, holding manoeuvres. 
Prevalence of Nocturnal enuresis is 15% in 5-year-old, 
7% in 7-year-old, 5% in 9-year-old, 2% in 15-year-old. 
Fewer than 1/3rd of the parents of a bedwetting child 
consults a doctor.  
 
IMPACT OF PRIMARY NOCTURNAL 
ENURESIS  
• Psychological well-being: It results in substantial 
feeling of shame, anger and inferiority, dangerous 
impairment of self-esteem, inability to socialize 
impacting outdoor activities and fear of public 
discovery haunts sufferers. 
• Parental Concern: NE imparts an emotional 
impact on child and effects the child’s social 
relationships leading the parents to think if their 
child is normal.  Parental concern also includes 
removing the smell from the bedroom, keeping it a 
secret and the extra washing, 
 
A family history of bedwetting strongly predicts 
bedwetting in children. As per literature, 73% of 
children affected by bedwetting have first degree 
relatives with a history of bedwetting, the age of 
attaining dryness is delayed by 1.5 years if both 
parents have a history of bedwetting, risk of 
bedwetting is 5–7 times higher if one parent has a 
history of bedwetting and 11.3 times higher if both 
parents are affected. The gene responsible is ENURI 1 





KEY PATHOGENIC MECHANISMS 
UNDERLYING NOCTURNAL ENURESIS 
Nocturnal Polyuria 
• Nocturnal urine production>130% of expected 
bladder capacity (EBC) for age (normally decreases to 
50% of daytime) +/- Reduced or abnormal bladder 
reservoir function at night. 
Bladder Function Problems 
• Functional bladder capacity (FBC) is vital for NE, 
Bladder capacity: {Age (in years) + 2} x 30 ml, in 
enuretics, nighttime BC is lower, but in non 
enuretics: 1.6 – 2 times larger than day time BC. There 
can be detrusor over activity in absence of Lower 
urinary tract symptoms. Constipation and urinary 
tract infections can cause detrusor over activity. 
 
CONSERVATIVE MANAGEMENT 
• Timed voiding – voiding every 3-4 hours (discourage 
holding), Voiding immediately upon rising in 
morning and before bed, Adequate hydration, 
Distribute fluid intake (40% morning, 40% afternoon, 
20% evening). 
• Treat constipation, Proper positioning on the toilet 
seat, encourage child to take time on toilet to empty 
completely, Encourage physical activity – discourage 
TV / Computer for long duration, motivational 
therapy like Star charts should be started. 
• Alarm Therapy: 60-70% Effective but labour 
extensive, Moisture sensor and alarm which rings 
when child wets, Conditioning - teaches child to wake 
to a full bladder before wetting, May be used in 
combination with DDAPV and/or oxybutynin, 30-
40% subjects discontinue therapy. 
• Dry Bed training: Waking the child on a schedule of 
decreasing intervals over several nights, The child is 
made to change clothes and bedding (if wet), and 
walk to the toilet if voiding is required. 
• Motivational Therapy: Combination of providing 
reassurance, emotional support, eliminating guilt, 
and rewarding the child for dry nights, Cleaning after 
bedwetting should not be performed as a 
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juices, and fluids 2 hours before bedtime, voiding just 
before bed. 
 
PHARMACOLOGICAL THERAPY OF 
ENURESIS: OXYBUTININ AND 
TOLTERODINE 
• Primarily to treat children with daytime urgency or 
frequency as well as night-time enuresis, Small 
capacity bladder when Neurogenic component is 
ruled out, Children with PMNE only where primary 
treatment has failed, Act mainly by suppressing 
detrusor over activity. 
• Side effects include flushing, blurred vision, 
constipation, tremor, decreased salivation and 
decreased ability to sweat. 
• WHO & NICE has now endorsed that Imipramine 
cannot be recommended for treatment of PNE. 
• Desmopressin: Pharmacologic therapies for 
nocturnal enuresis decrease the frequency of enuresis 
and temporarily resolve symptoms until spontaneous 
resolution occurs, the response rate to desmopressin 
therapy is 60%–70%, but relapse rates are high. The 
NE indication has been withdrawn from the 
intranasal spray in most countries due to 
unpredictability of dosing and increased risk of 
hyponatremia. The combination of an enuresis alarm 
with desmopressin may be superior to the use of 
desmopressin alone. Children with Nocturnal 
Polyuria are most likely to benefit from desmopressin 
since lower nocturnal vasopressin levels have been 
demonstrated in a large percentage of patients, 
making substitution with desmopressin, a rational 
first-line treatment for children with MNE and NP. 
 
One must rule out the following before starting 
enuresis treatment: Constipation/Encopresis, 
Recurrent UTI’s: Reflux disorders, Abnormal urine 
analysis, Sleep disorders : OSA , Underlying DM / DI, 
Neuropsychiatric conditions like ADHD & Learning 
disabilities, Spinal dysraphism / lower limb weakness 
/ patulous anus, Failure to thrive : Renal tubular 
acidosis, Bony deformities due to CKD / RTA, 
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